Advertisement
UK markets close in 1 hour 45 minutes

  • FTSE 100

    8,443.41
    +62.06 (+0.74%)
     

  • FTSE 250

    20,680.70
    +149.40 (+0.73%)
     

  • AIM

    789.69
    +5.99 (+0.76%)
     

  • GBP/EUR

    1.1620
    +0.0009 (+0.07%)
     

  • GBP/USD

    1.2535
    +0.0011 (+0.09%)
     

  • Bitcoin GBP

    50,214.60
    +1,542.71 (+3.17%)
     

  • CMC Crypto 200

    1,300.62
    -57.39 (-4.23%)
     

  • S&P 500

    5,236.54
    +22.46 (+0.43%)
     

  • DOW

    39,545.66
    +157.90 (+0.40%)
     

  • CRUDE OIL

    79.92
    +0.66 (+0.83%)
     

  • GOLD FUTURES

    2,373.50
    +33.20 (+1.42%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,779.74
    +93.14 (+0.50%)
     

  • CAC 40

    8,231.37
    +43.72 (+0.53%)
     
PROPERTY:

Homes with investment potential

These residential properties could bring in a good ROI

This Biotech Stock Just Pushed Back A Key Trial Until Early 2018

ALLISON GATLIN
Updated
This Biotech Stock Just Pushed Back A Key Trial Until Early 2018

Intercept will push a Phase 3 study of its liver disease drug, Ocaliva, in cirrhotic nonalcoholic steatohepatitis into the first quarter, an analyst said Thursday.

Continue reading